AC1903 is a specific inhibitor of TRPC5 channel, and has been shown to suppress severe proteinuria and prevent podocyte loss.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 111 | |
10 mg | In stock | $ 199 | |
20 mg | In stock | $ 300 | |
50 mg | In stock | $ 544 | |
100 mg | In stock | $ 854 |
Description | AC1903 is a specific inhibitor of TRPC5 channel, and has been shown to suppress severe proteinuria and prevent podocyte loss. |
Targets&IC50 | TRPC5 current IN HEK-293 cells:14.7 μM (IC50) |
In vivo | AC1903, that specifically blocks TRPC5 channel activity in glomeruli of proteinuric rats.?Chronic administration of AC1903 suppressed severe proteinuria and prevented podocyte loss in a transgenic rat model of FSGS.AC1903 also provided therapeutic benefit in a rat model of hypertensive proteinuric kidney disease.?TRPC5 activity drives disease and that TRPC5 inhibitors may be valuable for the treatment of progressive kidney diseases. |
CAS No. | 831234-13-0 |
Chemical Formula | C19H17N3O |
Molecular Weight | 303.365 |
Solubility | DMSO: 10 mM |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom